QSI vs. DCGO, ORGN, FARO, MASS, GEOS, LTCH, AATC, OWLT, APPH, and SPEC
Should you be buying Quantum-Si stock or one of its competitors? The main competitors of Quantum-Si include DocGo (DCGO), Origin Materials (ORGN), FARO Technologies (FARO), 908 Devices (MASS), Geospace Technologies (GEOS), Latch (LTCH), Autoscope Technologies (AATC), Owlet (OWLT), AppHarvest (APPH), and Spectaire (SPEC).
DocGo (NASDAQ:DCGO) and Quantum-Si (NASDAQ:QSI) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, dividends, media sentiment, earnings, community ranking, analyst recommendations, profitability and risk.
DocGo has a net margin of 2.98% compared to DocGo's net margin of -7,145.76%. Quantum-Si's return on equity of 6.20% beat DocGo's return on equity.
In the previous week, Quantum-Si had 2 more articles in the media than DocGo. MarketBeat recorded 3 mentions for Quantum-Si and 1 mentions for DocGo. Quantum-Si's average media sentiment score of 0.63 beat DocGo's score of 0.62 indicating that DocGo is being referred to more favorably in the media.
DocGo presently has a consensus target price of $7.75, indicating a potential upside of 164.51%. Quantum-Si has a consensus target price of $2.67, indicating a potential upside of 75.44%. Given Quantum-Si's stronger consensus rating and higher probable upside, analysts plainly believe DocGo is more favorable than Quantum-Si.
DocGo received 37 more outperform votes than Quantum-Si when rated by MarketBeat users. Likewise, 73.21% of users gave DocGo an outperform vote while only 66.67% of users gave Quantum-Si an outperform vote.
DocGo has a beta of 0.96, suggesting that its stock price is 4% less volatile than the S&P 500. Comparatively, Quantum-Si has a beta of 3.04, suggesting that its stock price is 204% more volatile than the S&P 500.
56.4% of DocGo shares are owned by institutional investors. Comparatively, 39.9% of Quantum-Si shares are owned by institutional investors. 2.7% of DocGo shares are owned by insiders. Comparatively, 30.0% of Quantum-Si shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
DocGo has higher revenue and earnings than Quantum-Si. Quantum-Si is trading at a lower price-to-earnings ratio than DocGo, indicating that it is currently the more affordable of the two stocks.
Summary
DocGo beats Quantum-Si on 14 of the 18 factors compared between the two stocks.
Get Quantum-Si News Delivered to You Automatically
Sign up to receive the latest news and ratings for QSI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding QSI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Quantum-Si Competitors List
Related Companies and Tools
